| New Technology to Detect Cancer Mutations Earlier |
 |
| Written by News | |||
| Tuesday, 05 April 2011 14:00 | |||
Life Technologies Corporation says it has launched TaqMan Mutation Detection Assays, a highly sensitive molecular analysis tool that can detect a single mutant molecule hiding in a background of one million normal copies. The tool was developed to screen for extremely minute levels of mutations in cancer-related genes. The company claims that the TaqMan Mutation Detection Assays show at least 10-fold greater sensitivity than is currently available. The assays will also support the development of emerging technologies and future products for detecting circulating tumor cells (CTCs), which scientists in the United Kingdom recently said could help determine aggressiveness levels and potential treatments for the disease. The tool will be available as part of an early release program with a full launch in July.
View all articles by this author
|
About the Author: Jeff Merron is a full-time freelance editor, journalist, and copywriter who has written for the New York Times Magazine, ESPN.com, Slate, Byte Magazine, Macworld, Consumers Digest, and many other national publications. He's also a regular contributor to IT Business Insider and 108, a baseball magazine. He has a Ph.D. in Mass Communication Research from the University of North Carolina at Chapel Hill.
|
